Your browser doesn't support javascript.
loading
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.
Marks, David I; Kebriaei, Partow; Stelljes, Matthias; Gökbuget, Nicola; Kantarjian, Hagop; Advani, Anjali S; Merchant, Akil; Stock, Wendy; Cassaday, Ryan D; Wang, Tao; Zhang, Hui; Loberiza, Fausto; Vandendries, Erik; DeAngelo, Daniel J.
Afiliación
  • Marks DI; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Trust, Bristol, United Kingdom. Electronic address: David.Marks@UHBristol.nhs.uk.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy and Department of Leukemia, MD Anderson Cancer Center, Houston, Texas.
  • Stelljes M; Department of Medicine/Hematology and Oncology, University of Muenster, Münster, Münster, Germany.
  • Gökbuget N; Department of Medicine II, Department of Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany.
  • Kantarjian H; Department of Stem Cell Transplantation and Cellular Therapy and Department of Leukemia, MD Anderson Cancer Center, Houston, Texas.
  • Advani AS; Division of Hematology/Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Merchant A; Cedars-Sinai Medical Center, Los Angeles, California.
  • Stock W; Section of Hematology/Oncology, Department of Medicine, and University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, Illinois.
  • Cassaday RD; Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Wang T; Pfizer, Inc, Groton, Connecticut.
  • Zhang H; Pfizer, Inc, Shanghai, China.
  • Loberiza F; Pfizer, Inc, New York, New York.
  • Vandendries E; Pfizer, Inc, Cambridge, Massachusetts.
  • DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Biol Blood Marrow Transplant ; 25(9): 1720-1729, 2019 09.
Article en En | MEDLINE | ID: mdl-31039409
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Inotuzumab Ozogamicina Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Inotuzumab Ozogamicina Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article